Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Fanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 113
Immune response in COVID-19: what is next?
Qing Li, Ying Wang, Qiang Sun, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1107-1122
Open Access | Times Cited: 110
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin C. Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 88
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
M. Alejandra Tortorici, Amin Addetia, Albert J. Seo, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 904-911.e4
Open Access | Times Cited: 51
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 65
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
Rong Tang, Hui Zheng, Busen Wang, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 7, pp. 613-623
Open Access | Times Cited: 31
Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults
Chanchan Xiao, Zhiyao Ren, Bei Zhang, et al.
Nature Aging (2023) Vol. 3, Iss. 4, pp. 418-435
Open Access | Times Cited: 24
PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals
Amitis Ramezani, Rahim Sorouri, Saiedeh Haji‐Maghsoudi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes
Achilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses (2024) Vol. 16, Iss. 5, pp. 685-685
Open Access | Times Cited: 9
A mini review of reinfection with the SARS‐CoV‐2 Omicron variant
Hongwei Shen, Dingqiang Chen, Chenglin Li, et al.
Health Science Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 7
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study
Soledad González, Santiago Olszevicki, Alejandra Gaiano, et al.
The Lancet Regional Health - Americas (2022) Vol. 13, pp. 100316-100316
Open Access | Times Cited: 33
“Is Omicron mild”? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies
Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3521-3539
Open Access | Times Cited: 29
Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
Qiong Wang, Sheng‐Bao Ye, Zhijian Zhou, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 28
Hybrid and herd immunity 6 months after SARS-CoV-2 exposure among individuals from a community treatment program
Parawee Chevaisrakul, Putthapoom Lumjiaktase, Pongtorn Kietdumrongwong, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Analyzing immune responses to varied mRNA and protein vaccine sequences
Hyeong-Jun Park, Yoo‐Jin Bang, Sung Pil Kwon, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape
Weiqi Deng, Xuefeng Niu, Ping He, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Neutralizing and binding antibody dynamics following primary and booster COVID-19 vaccination among healthcare workers
Irmak Güzel, Gamze ÖZTÜRK, Özgür Appak, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants
Danyi Ao, Dandan Peng, Cai He, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
A highly efficient needle-free-injection delivery system for mRNA-LNP vaccination against SARS-CoV-2
Shanhong Mao, Shiyou Li, Yuxin Zhang, et al.
Nano Today (2022) Vol. 48, pp. 101730-101730
Open Access | Times Cited: 26
Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review
Yuxuan Du, Long Chen, Yuan Shi
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 25
Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
Birte Möhlendick, Ieva Čiučiulkaitė, Carina Elsner, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top